NO911787L - Peptidaminer samt fremgangsmaate for fremstilling derav ogmidler som inneholder disse som fibrin/-trombin-koaguleringsinhibitorer - Google Patents

Peptidaminer samt fremgangsmaate for fremstilling derav ogmidler som inneholder disse som fibrin/-trombin-koaguleringsinhibitorer

Info

Publication number
NO911787L
NO911787L NO91911787A NO911787A NO911787L NO 911787 L NO911787 L NO 911787L NO 91911787 A NO91911787 A NO 91911787A NO 911787 A NO911787 A NO 911787A NO 911787 L NO911787 L NO 911787L
Authority
NO
Norway
Prior art keywords
amino acid
peptidamines
fibrin
procedures
preparing
Prior art date
Application number
NO91911787A
Other languages
English (en)
Norwegian (no)
Other versions
NO911787D0 (no
Inventor
Werner Stueber
Karl Fickenscher
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO911787D0 publication Critical patent/NO911787D0/no
Publication of NO911787L publication Critical patent/NO911787L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO91911787A 1990-05-08 1991-05-07 Peptidaminer samt fremgangsmaate for fremstilling derav ogmidler som inneholder disse som fibrin/-trombin-koaguleringsinhibitorer NO911787L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014655A DE4014655A1 (de) 1990-05-08 1990-05-08 Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren

Publications (2)

Publication Number Publication Date
NO911787D0 NO911787D0 (no) 1991-05-07
NO911787L true NO911787L (no) 1991-11-11

Family

ID=6405908

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911787A NO911787L (no) 1990-05-08 1991-05-07 Peptidaminer samt fremgangsmaate for fremstilling derav ogmidler som inneholder disse som fibrin/-trombin-koaguleringsinhibitorer

Country Status (13)

Country Link
US (2) US5478810A (fr)
EP (1) EP0456152B1 (fr)
JP (1) JP3090495B2 (fr)
KR (1) KR0181512B1 (fr)
AT (1) ATE172987T1 (fr)
AU (1) AU642733B2 (fr)
CA (1) CA2042001C (fr)
DE (2) DE4014655A1 (fr)
DK (1) DK0456152T3 (fr)
ES (1) ES2125225T3 (fr)
IE (1) IE911548A1 (fr)
NO (1) NO911787L (fr)
PT (1) PT97583B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014655A1 (de) * 1990-05-08 1991-11-14 Behringwerke Ag Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren
DE4133946A1 (de) * 1991-10-14 1993-04-15 Behringwerke Ag Funktioneller test und reagenz zur bestimmung von fibrinogen
DE4242736A1 (de) * 1992-12-17 1994-06-23 Behringwerke Ag Synthetische Peptide, Antikörper dagegen und ihre Verwendung
EP1115847A1 (fr) * 1998-09-25 2001-07-18 Children's Medical Center Corporation Peptides courts modulant selectivement l'activite des proteines kinases
JP2003506411A (ja) * 1999-08-09 2003-02-18 トリペップ アクチ ボラゲット タンパク質重合阻害剤および使用方法
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
MXPA02002578A (es) 1999-09-08 2002-10-23 Guilford Pharm Inc Compuestos de union a ciclofilina no peptidicos, y su uso.
EP1360173A2 (fr) 2001-01-25 2003-11-12 Guilford Pharmaceuticals Inc. Composes de liaison de la cyclophiline carboxylique trisubstituee et leur utilisation
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
ATE505479T1 (de) * 2001-09-10 2011-04-15 Novel Science Internat Gmbh Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
WO2003024995A1 (fr) * 2001-09-19 2003-03-27 Tripep Ab Molecules bloquant l'infectivite virale et methodes d'utilisation associees
CA2515679A1 (fr) * 2003-02-21 2004-09-02 Tripep Ab Derive du glycinamide destine a inhiber la replication du vih
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
DE102004059055A1 (de) 2004-12-07 2006-06-08 Dade Behring Marburg Gmbh Verfahren zur automatischen Bestimmung des endogenen Thrombinpotenzials
CA2588560A1 (fr) * 2004-12-29 2006-07-06 Labo Cosprophar Ag Composition cosmetique a application cutanee appropriee pour detendre des rides d'expression
DE102005003145B4 (de) * 2005-01-21 2006-10-19 Dade Behring Marburg Gmbh Stablies, chromogenes Flüssigreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
US7442323B2 (en) * 2006-06-02 2008-10-28 E. I. Du Pont De Nemours And Company Potassium monopersulfate solutions
US7851587B2 (en) * 2006-10-02 2010-12-14 The Board Of Trustees Of The Leland Stanford Junior University Peptides derived from the C2 domain of epsilon PKC
DE102009048199A1 (de) 2009-10-05 2011-04-21 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Bestimmung von Faktor XIII mit Hilfe von Referenzmaterial auf Plasmabasis
DE102009048198A1 (de) 2009-10-05 2011-04-21 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Bestimmung von Faktor XIII mittels NAD(P)H-Analoga
EP2333555A1 (fr) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Test de coagulation hétérogène
EP2395354A1 (fr) 2010-06-10 2011-12-14 Siemens Healthcare Diagnostics Products GmbH Test d'activité homogène destiné à la détermination de réactions enzymatiques
EP2465941A1 (fr) 2010-12-20 2012-06-20 Siemens Healthcare Diagnostics Products GmbH Procédé de détermination simultanée de plusieurs protéases de coagulation
EP2471945A1 (fr) 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Procédé de détermination d'inhibiteurs de coagulation
ES2623979T3 (es) 2013-03-21 2017-07-12 Sanofi-Aventis Deutschland Gmbh Síntesis de productos peptídicos que contienen hidantoína
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
US20220120768A1 (en) * 2018-12-07 2022-04-21 A&T Corporation Reagent for measuring fibrinogen
JP7359538B2 (ja) * 2018-12-07 2023-10-11 株式会社エイアンドティー フィブリノゲン測定試薬
JP7410652B2 (ja) * 2019-04-12 2024-01-10 株式会社エイアンドティー フィブリノゲンの定量方法
CN110669126B (zh) * 2019-10-23 2022-08-16 广州领晟医疗科技有限公司 多肽gpr5及其促进肝细胞增殖和抑制肝细胞凋亡的用途
CN112206307B (zh) * 2020-09-15 2023-12-05 广州领晟医疗科技有限公司 一种可注射的温敏型水凝胶及其制备方法与应用
EP4239338A1 (fr) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Essai général destiné à la détermination de l'état du système de coagulation sanguine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811647A1 (de) * 1988-04-07 1989-10-26 Behringwerke Ag Verfahren und verpackung enthaltend mittel zur kinetischen bestimmung von faktor xiii
DE4014655A1 (de) * 1990-05-08 1991-11-14 Behringwerke Ag Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren

Also Published As

Publication number Publication date
DE59109067D1 (de) 1998-12-10
AU642733B2 (en) 1993-10-28
KR910020031A (ko) 1991-12-19
CA2042001C (fr) 2002-01-08
NO911787D0 (no) 1991-05-07
DE4014655A1 (de) 1991-11-14
JPH0789990A (ja) 1995-04-04
JP3090495B2 (ja) 2000-09-18
IE911548A1 (en) 1991-11-20
US5607858A (en) 1997-03-04
CA2042001A1 (fr) 1991-11-09
US5478810A (en) 1995-12-26
EP0456152A2 (fr) 1991-11-13
EP0456152A3 (en) 1992-07-22
PT97583A (pt) 1992-02-28
AU7622291A (en) 1991-11-14
ES2125225T3 (es) 1999-03-01
KR0181512B1 (ko) 1999-04-01
ATE172987T1 (de) 1998-11-15
DK0456152T3 (da) 1999-07-19
PT97583B (pt) 1998-08-31
EP0456152B1 (fr) 1998-11-04

Similar Documents

Publication Publication Date Title
NO911787L (no) Peptidaminer samt fremgangsmaate for fremstilling derav ogmidler som inneholder disse som fibrin/-trombin-koaguleringsinhibitorer
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
TW377350B (en) Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
EP0319506A3 (en) Novel platelet-aggregation inhibitor peptide derivatives
RU94032284A (ru) Карбоксамиды, способ их получения, фармацевтическая композиция, применение
EP0254080A3 (en) Malonic acid derivatives and methods for their synthesis
NZ336116A (en) Diagnostic agent comprising an amino acid or peptide containing at least one 13C or 14C for pancreatic exocrine function
WO1996021740A1 (fr) Procedes pour la determination du potentiel thrombine endogene (etp), et substrats pour thrombine utilises dans ces procedes
DK0679631T3 (da) Biaromatiske adamantylgruppeholdige acetylenforbindelser,farmaceutiske og kosmetiske sammensætninger, der indeholder disse,
ATE357456T1 (de) Mittel zur förderung von knochenbildung
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
DE69017180D1 (de) Biologisch wirksame polymere arzneistoffderivate.
ITRM910189A1 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
ATE61567T1 (de) Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern, verwendung zur synthese von carboxyalkyldipeptiden.
BR9803914A (pt) Lantibióticos relacionados a actagardina e processos para sua preparação e uso.
ATE131492T1 (de) Synthetische peptide und deren mischungen für den nachweis von hiv-antikörpern
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
DE69526462D1 (de) Verfahren zur Herstellung von Peptiden aus N-Carboxyanhydridaminosäuren
DE69428401D1 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
Midura-Nowaczek et al. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors
DE3887854D1 (de) Verfahren zur Herstellung von Dipeptiden.
ES2115535B1 (es) Procedimiento para la preparacion de amidas de d-(-)-aminoacidos.
JPS6485996A (en) Peptide derivative and method for using said derivative
HUP0003500A2 (hu) Adhézió inhibitor ciklopeptidszármazékok, azokat tartalmazó gyógyszerkészítmények, eljárás előállításukra, és alkalmazásuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application